TAMPA, Fla. —Aspirin as a thromboprophylaxis agent was non-inferior to low-molecular-weight heparin for all-cause mortality in patients with extremity, pelvic or acetabular fractures, presented results showed.
“Venous thromboembolism (VTE) is a well-recognized, potentially fatal complication after orthopedic trauma. Current guidelines recommend low-molecular-weight heparin (LMWH) for VTE prophylaxis,” Robert V. O’Toole, MD, said in his presentation at the Orthopaedic Trauma Association Annual Meeting. “However, arthroplasty literature suggests aspirin may be